Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Transplantation

• Publication date

  1991-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199109000-00019PMID 1897021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propagation and characterization of lymphocytes from transplant biopsies.

  1991cited by this paper
• HLA-DQw1 compatibility and cadaveric renal allograft survival.

  1990cited by this paper
• Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.

  1990cited by this paper
• Predictive implications of bioptic diagnosis in cardiac allografts.

  1989cited by this paper
• Effect of HLA matching in heart transplantation. Collaborative Heart Transplant Study.

  1989cited by this paper
• Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.

  1989cited by this paper
• Anti-HLA antibodies and heart allograft survival.

  1989cited by this paper
• HLA-DQ mismatches between donor and recipient in the presence of HLA-DR compatibility do not influence the function or outcome of renal transplants.

  1989cited by this paper
• The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival.

  1989cited by this paper
• THE IMPACT OF HLA A, B, AND DR BLOOD TRANSFUSIONS AND IMMUNE RESPONDER STATUS ON CARDIAC ALLOGRAFT RECIPIENTS TREATED WITH CYCLOSPORINE

  1988cited by this paper
• Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection.

  1988cited by this paper
• Human heart transplantation. Rejection risk factors.

  1988cited by this paper
• HLA compatibility and cardiac transplant recipient survival.

  1987cited by this paper
• The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.

  1987cited by this paper
• Association of MB compatibility with successful intrafamilial kidney transplantation.

  1980cited by this paper

• Bridge-to-transplant temporary mechanical circulatory support and risk of allosensitization

  2024cites this paper
• Histocompatibility Testing in the Transplant Setting

  2017cites this paper
• Sensitization in Left Ventricular Assist Device Recipients Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA

  2013cites this paper
• Single Donor Allografts: Report of Nine Cases Long-Term Follow-Up of Simultaneous Heart and Kidney Transplantation With

  2013cites this paper
• Combined heart and kidney transplantation: long-term analysis of renal function and major adverse events at 20 years.

  2010cites this paper
• Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.

  2009cites this paper
• Association of device surface and biomaterials with immunologic sensitization after mechanical support.

  2008cites this paper
• Relevance of Antibody Screening and Crossmatching in Solid Organ, Hematopoietic Stem Cell Transplantation, and Blood Transfusion

  2008cites this paper
• Long-term follow-up of simultaneous heart and kidney transplantation with single donor allografts: report of nine cases.

  2007cites this paper
• Update on cardiac transplantation pathology.

  2007cites this paper
• Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.

  2006cites this paper
• Use of rituximab to decrease panel-reactive antibodies.

  2005cites this paper
• Surrogate Markers for Late Cardiac Allograft Survival

  2004cites this paper
• De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system.

  2004cites this paper
• The effect of novel immunosuppressants on extracellular matrix remodelling and the expression of fibrosis associated genes in an experimental model of allograft vasculopathy

  2003cites this paper
• Allosensitization in heart transplantation: implications and management strategies

  2003cites this paper
• Cardiac Allograft Rejection

  2001cites this paper
• Clinical Diagnosis and Management of Cardiac Allograft Rejection and Maintenance Immunosuppression

  2001cites this paper
• Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.

  2000cites this paper
• THE RELATIONSHIP BETWEEN ACUTE REJECTION AND CHRONIC REJECTION IS HIGHLY DEPENDENT ON SPECIFIC MHC MATCHING

  2000cites this paper
• The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry.

  2000cites this paper
• Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts.

  1999cites this paper
• The significance of HLA matching in cardiac transplantation.

  1999cites this paper
• Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.

  1998cites this paper
• Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.

  1998cites this paper
• Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation.

  1998cites this paper
• The Role of Immune Mechanisms in Cardiovascular Disease

  1997cites this paper
• Donor criteria and evaluation.

  1997cites this paper
• Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay.

  1997cites this paper
• Human leukocyte antigen compatibility in heart transplantation: evidence for a differential role of HLA matching on short- and medium-term patient survival.

  1997cites this paper
• The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group.

  1997cites this paper
• Combined heart and kidney transplantation: an effective therapeutic option--report of six cases.

  1997cites this paper
• Immunogenetics of Heart Transplantation in Rodents

  1997cites this paper
• Transplant Associated Coronary Artery Disease

  1997cites this paper
• Pretransplant Immunological Considerations

  1996cites this paper
• Donor‐specific HLA antibodies after transplantation are associated with deterioration in cardiac function

  1996cites this paper
• Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.

  1996cites this paper
• Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.

  1996cites this paper
• Human Leukocyte Antigen Matching, Radiographic Score, and Histologic Findings in Massive Frozen Bone Allografts

  1996cites this paper
• Effect of crossmatching on outcome in organ transplantation.

  1995cites this paper
• Increased early mortality in women undergoing cardiac transplantation.

  1995cites this paper
• Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching.

  1995cites this paper
• Early Rejection of Human Cardiac Allografts Is a Risk Factor for Multiple Rejection Episodes

  1995cites this paper
• IgG DONOR‐SPECIFIC CROSSMATCHES ARE NOT ASSOCIATED WITH GRAFT REJECTION OR POOR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: AN ASSESSMENT BY CYTOTOXICITY AND FLOW CYTOMETRY

  1995cites this paper
• HLA matching and cardiac transplantation.

  1994cites this paper
• THE RELATIONSHIP AMONG DONOR‐RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1

  1994cites this paper
• REJECTION IN HEART TRANSPLANTATION STRONGLY CORRELATES WITH HLA‐DR ANTIGEN MISMATCH

  1994cites this paper
• The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study.

  1994cites this paper
• A highly sensitive, rapid screening method for the detection of antibodies directed against HLA class I and II antigens

  1993cites this paper
• LUNG TRANSPLANTATION IN PATIENTS OVER THE AGE OF 50

  1993cites this paper
• The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation.

  1993cites this paper
• Neonatal cardiac transplantation. Intermediate-term results and incidence of rejection. Loma Linda University Pediatric Heart Transplant Group.

  1992cites this paper